Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-25 | New | $10,784,000 | $10,784,000 | Equity and Debt | 06b | SEC link |
| 2023-11-03 | New | $13,650,000 | $13,650,000 | Equity Only | 06b | SEC link |
| 2023-11-03 | New | $12,705,496 | $12,705,496 | Equity Only | 06b | SEC link |
| 2023-11-03 | New | $34,675,000 | $34,675,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Indrani Egleston | Executive |
| Vinod K. Goel | Executive |
| Vikash Goel | Executive |
| Jai N. Gupta | Director |
| Gulam Khan | Director, Executive |
| Arnaud Marie | Director |
| Phil Rackliffe | Director, Executive |
| Akhil Saklecha | Director |
| Todd Schwarzinger | Director |
| Karen Shanahan | Director |
| Michael Whitman | Director |
| Mitch Wolf | Director |
| Jim Zalar | Director |